236 related articles for article (PubMed ID: 17129655)
1. Hemoglobin adducts of the human bladder carcinogen o-toluidine after treatment with the local anesthetic prilocaine.
Gaber K; Harréus UA; Matthias C; Kleinsasser NH; Richter E
Toxicology; 2007 Jan; 229(1-2):157-64. PubMed ID: 17129655
[TBL] [Abstract][Full Text] [Related]
2. Quantification of systemic o-toluidine after intrathecal administration of hyperbaric prilocaine in humans: a prospective cohort study.
Guntz E; Carini A; Koslitz S; Brüning T; Kapessidou P; Weiss T
Arch Toxicol; 2021 Mar; 95(3):925-934. PubMed ID: 33475793
[TBL] [Abstract][Full Text] [Related]
3. Characterization of 4-aminobiphenyl-hemoglobin adducts in maternal and fetal blood-samples.
Myers SR; Spinnato JA; Pinorini-Godly MT; Cook C; Boles B; Rodgers GC
J Toxicol Environ Health; 1996 Apr; 47(6):553-66. PubMed ID: 8614023
[TBL] [Abstract][Full Text] [Related]
4. CYP1A2 and NAT2 phenotyping and 3-aminobiphenyl and 4-aminobiphenyl hemoglobin adduct levels in smokers and non-smokers.
Sarkar M; Stabbert R; Kinser RD; Oey J; Rustemeier K; von Holt K; Schepers G; Walk RA; Roethig HJ
Toxicol Appl Pharmacol; 2006 Jun; 213(3):198-206. PubMed ID: 16405939
[TBL] [Abstract][Full Text] [Related]
5. N-acetyltransferase 2 phenotype but not NAT1*10 genotype affects aminobiphenyl-hemoglobin adduct levels.
Probst-Hensch NM; Bell DA; Watson MA; Skipper PL; Tannenbaum SR; Chan KK; Ross RK; Yu MC
Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):619-23. PubMed ID: 10868698
[TBL] [Abstract][Full Text] [Related]
6. Frequency of urination and its effects on metabolism, pharmacokinetics, blood hemoglobin adduct formation, and liver and urinary bladder DNA adduct levels in beagle dogs given the carcinogen 4-aminobiphenyl.
Kadlubar FF; Dooley KL; Teitel CH; Roberts DW; Benson RW; Butler MA; Bailey JR; Young JF; Skipper PW; Tannenbaum SR
Cancer Res; 1991 Aug; 51(16):4371-7. PubMed ID: 1868460
[TBL] [Abstract][Full Text] [Related]
7. Analysis of 4-aminobiphenyl hemoglobin adducts in smokers and nonsmokers by pseudo capillary on-column gas chromatography- tandem mass spectrometry.
Seyler TH; Reyes LR; Bernert JT
J Anal Toxicol; 2010; 34(6):304-11. PubMed ID: 20663282
[TBL] [Abstract][Full Text] [Related]
8. Hemoglobin adducts of 4-aminobiphenyl in smokers and nonsmokers.
Bryant MS; Skipper PL; Tannenbaum SR; Maclure M
Cancer Res; 1987 Jan; 47(2):602-8. PubMed ID: 3791245
[TBL] [Abstract][Full Text] [Related]
9. Haemoglobin adducts of aromatic amines in people exposed to cigarette smoke.
Bryant MS; Vineis P; Skipper PL; Tannenbaum SR
IARC Sci Publ; 1988; (89):133-6. PubMed ID: 3198197
[TBL] [Abstract][Full Text] [Related]
10. Detection of carcinogen-DNA adducts in exfoliated urothelial cells of cigarette smokers: association with smoking, hemoglobin adducts, and urinary mutagenicity.
Talaska G; Schamer M; Skipper P; Tannenbaum S; Caporaso N; Unruh L; Kadlubar FF; Bartsch H; Malaveille C; Vineis P
Cancer Epidemiol Biomarkers Prev; 1991; 1(1):61-6. PubMed ID: 1845172
[TBL] [Abstract][Full Text] [Related]
11. Monoarylamines in the general population--a cross-sectional population-based study including 1004 Bavarian subjects.
Kütting B; Göen T; Schwegler U; Fromme H; Uter W; Angerer J; Drexler H
Int J Hyg Environ Health; 2009 May; 212(3):298-309. PubMed ID: 18789761
[TBL] [Abstract][Full Text] [Related]
12. 4-Aminobiphenyl hemoglobin adducts in fetuses exposed to the tobacco smoke carcinogen in utero.
Coghlin J; Gann PH; Hammond SK; Skipper PL; Taghizadeh K; Paul M; Tannenbaum SR
J Natl Cancer Inst; 1991 Feb; 83(4):274-80. PubMed ID: 1994056
[TBL] [Abstract][Full Text] [Related]
13. Alkylaniline-hemoglobin adducts and risk of non-smoking-related bladder cancer.
Gan J; Skipper PL; Gago-Dominguez M; Arakawa K; Ross RK; Yu MC; Tannenbaum SR
J Natl Cancer Inst; 2004 Oct; 96(19):1425-31. PubMed ID: 15467031
[TBL] [Abstract][Full Text] [Related]
14. DNA adducts of ortho-toluidine in human bladder.
Böhm F; Schmid D; Denzinger S; Wieland WF; Richter E
Biomarkers; 2011 Mar; 16(2):120-8. PubMed ID: 21117897
[TBL] [Abstract][Full Text] [Related]
15. Measurement of 4-aminobiphenyl-hemoglobin adducts in lung cancer cases and controls.
Weston A; Caporaso NE; Taghizadeh K; Hoover RN; Tannenbaum SR; Skipper PL; Resau JH; Trump BF; Harris CC
Cancer Res; 1991 Oct; 51(19):5219-23. PubMed ID: 1913645
[TBL] [Abstract][Full Text] [Related]
16. [Methemoglobinemia due to prilocaine after plexus anesthesia. Reduction by prophylactic administration of ascorbic acid?].
Kortgen A; Janneck U; Vetsch A; Bauer M
Anaesthesist; 2003 Nov; 52(11):1020-6. PubMed ID: 14992088
[TBL] [Abstract][Full Text] [Related]
17. Biomonitoring of smoke constituents: exposure to 4-aminobiphenyl and 4-aminobiphenyl hemoglobin adduct levels in nonsmokers and smokers.
Schorp MK; Leyden DE
Inhal Toxicol; 2010 Aug; 22(9):725-37. PubMed ID: 20433335
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for prilocaine-induced methaemoglobinaemia following peripheral regional anaesthesia.
Vasters FG; Eberhart LH; Koch T; Kranke P; Wulf H; Morin AM
Eur J Anaesthesiol; 2006 Sep; 23(9):760-5. PubMed ID: 16723054
[TBL] [Abstract][Full Text] [Related]
19. Environmental tobacco smoke and bladder cancer risk in never smokers of Los Angeles County.
Jiang X; Yuan JM; Skipper PL; Tannenbaum SR; Yu MC
Cancer Res; 2007 Aug; 67(15):7540-5. PubMed ID: 17671226
[TBL] [Abstract][Full Text] [Related]
20. Measurement of the hemoglobin N-(2-oxoethyl)valine adduct in ethyl carbamate-treated mice.
Cai J; Myers SR; Hurst HE
Toxicol Appl Pharmacol; 1995 Mar; 131(1):73-9. PubMed ID: 7878680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
